Thank you again for submitting your work to Molecular Systems Biology. We have now heard back from the three referees who agreed to evaluate your manuscript. As you will see from the reports below, the referees raise substantial concerns on your work, which, I am afraid to say, preclude its publication in its present form.
Thank you again for submitting your work to Molecular Systems Biology. We have now heard back from the three referees who agreed to evaluate your manuscript. As you will see from the reports below, the referees raise substantial concerns on your work, which, I am afraid to say, preclude its publication in its present form.
While the reviewers generally found the goals of this manuscript potentially interesting, they raised a series of important concerns which they felt were sufficient to cast doubts on some of the key conclusions derived from these data. I would like to highlight two concerns which I feel are particularly important:
1. The first reviewer had issues related to the statistical analysis of this data, including concerns about the calculation of transcriptional rates, bimodality in the mRNA concentrations, and the validity of the linear regression methods used. This reviewer felt that addressing these potential problems could alter some of the main results of this work. Reviewer #3 (point #2) seems to have some similar concerns.
2. The second reviewer had substantial concerns regarding the physiological relevance of the turnover rates inferring from the actinomycin D experiments, and felt that these measurements either need to be supported with additional data or measured with a different, more accurate technology.
The reviewers do provide a series of constructive recommendations for additional experiments and analyses that may address these concerns. However, given the fundamental nature of these issues the editor would like to emphasize any revised work would need to conclusively address these issues and the others raised by the reviewers, and would likely require additional supporting experimental data, particular in regard to the latter point.
If you feel you can satisfactorily deal with these points and those listed by the referees, you may wish to submit a revised version of your manuscript. Please attach a covering letter giving details of the way in which you have handled each of the points raised by the referees. A revised manuscript will be once again subject to review and you probably understand that we can give you no guarantee at this stage that the eventual outcome will be favorable.
*PLEASE NOTE* As part of the EMBO Publications transparent editorial process initiative (see http://www.nature.com/msb/journal/v6/n1/full/msb201072.html), Molecular Systems Biology now publishes online a Review Process File with each accepted manuscript. Please be aware that in the event of acceptance, your cover letter/point-by-point document will be included as part of this file, which will be available to the scientific community. Authors may opt out of the transparent process at any stage prior to publication (contact us at msb@embo.org). More information about this initiative is available in our Instructions to Authors.
Thank you again for the opportunity to examine this work, and we look forward to receiving your revised manuscript.
Sincerely,
Editor -Molecular Systems Biology msb@embo.org ---------------------------------------------------------------------------Referee reports:
Reviewer #1 (Remarks to the Author):
Tippmann et al. present a manuscript in which they describe data on mRNA expression levels, Pol II binding, histone methylation, mRNA half-lives and miRNA targets both in mouse terminally differentiated cells (TN) and in pluripotent stem cells (ES) . The experiments appear to be wellperformed and the results are presented in a clear manner. However, I cannot accept this paper in its current form due to the following major criticisms.
1. The authors go into great depth in their explanation of the error models and the estimation of measurement noise. Well done. However, this is great contrast to several statistical issues I have with the analysis:
1A. The authors seem to either confuse *concentrations* with *rates* (i.e. mRNA concentration vs. transcription rate), or they fail to mention how they derive the actual transcription rates they claim to predict. I find that very confusing and ill-described. Transcription rates should be modeled according to something like dR/dt = k_transcription * DNA -k_degradation * RNA. Setting DNA concentration to 1 and assuming steady state (dR/dt = 0), we arrive at k_transcription = R*k_degradation. I do not see anything like that anywhere.
1B. Similarly, the authors claim that transcription rate should be proportional to mRNA levels. This would only be true at similar degradation rates (see 1A). The same applies to an inverse correlation between k_degradation and mRNA level. Rates are not concentrations.
1C. Examining the plots in the figures and the frequency distribution of mRNA concentrations, there is clearly a bi-modal distribution that has to be addressed. To my understanding, application of Pearson correlation coefficients is not appropriate in such bi-modal distributions. Further, I would argue to leave out the set of low-expression mRNAs completely, as they are likely non-functional (see Hebenstreit et al., Mol Sys Bio 2011) . Leaving this set out will improve several of the plots shown in the figures and likely change the authors' conclusions. If they prefer to leave the lowexpression mRNAs in, I would want to see separate discussion of their properties and a justification.
1D. Use of linear regression appears OK as most of the plots behave linearly (except for my criticism regarding bi-modality, 1C). However, I do not understand why the authors don't simply employ partial correlation analysis and multiple linear regression, but go through the somewhat convoluted pains of explaining their analysis of residuals. Please justify. I do not see why the analysis of residuals is valid over partial correlation analysis. (The authors may also want to discuss that they used linear correlation as an approximation but that that is not necessarily always correct).
1E. The expression *change* between TN and ES cells is in fact a difference (as explained in the Supplement). Now, this is very unusual to see, since most of the time one would examine log-ratios of fold-changes in expression (log(m(TN)/m(ES)). I am concerned that using differences (especially since their are NOT used in log-space) produces data that is not normally distributed and causes all sorts of problems (reasoning: mRNA levels are not normally distributed in first place). Please explain why differences are used and how that is correct.
2. The estimates of miRNA targets are done through KD of Dicer, and the authors claim that that method is better than other methods. I am not convinced, since a Dicer knockdown can also cause secondary effects (change in expression of genes that are targets of genes that are targets of miRNAs). Please justify why your method is better.
3. Again, possibly linked to the confusion of 1A. I do not see how chromatin features link to transcription rate.
4. In the supplement scatter plots of half-lives vs. other variables are shown. If the 20hr half-lives were left in the calculation of the correlation coefficients, then they seriously messed up the values for at least the upper two plots. The 20hr half-live datapoints were derived artificially and should be disregarded. I do actually think that some of the authors' claims on the minor role of degradation will change drastically when this is done, as I seem to see a correlation between half-life and mRNA levels.
Is the mRNA level log transformed or not? (Supplemental calculations)
Minor points: -It would be nice to mention the organism in the abstract.
-Please cite Mukherji, Nat Gen 2011 for the quote on miRNA as fine-tuners (p. 19) -p. 11 -leave out 'Surprisingly' as it is really not surprising given the indirect nature of the data -I think the analysis of tissue specificity is not particularly useful, but that's maybe personal taste -The linear regression, at least some of the error modeling, calculation of expression DIFFERENCE, transcription RATE, and the modeling should be explained in the main text (Methods).
- Figure 3C : I see a difference between orange and grey/blue boxes -Type in equ. 16, supplement Reviewer #2 (Remarks to the Author):
The paper by Tippmann et al. investigates the contribution of polII occupancy, histone marks and RNA half-lives on steady state RNA levels in stem cells and differentiated cells. The authors use chip-seq and actinomycin D inhibition experiments to measure gene expression at the chromatin and mRNA level. They observe that RNA levels can almost completely be predicted by H3K27me3 chip seq. Therefore, RNA levels are mainly controlled at the level of transcription. RNA degradation measured by actinomycin D treatment played only a minor role. Interestingly, changes in transcription rates were also able to predict changes in RNA levels when cells are differentiated. This is a very interesting piece of work that addresses a fundamental question. The dominance of transcription rates over RNA stability was recently reported in two other papers and is therefore not completely new (Rabani et al., 2011; Schwanhaeusser et al., 2011) . Nevertheless, this question was not yet addressed using chip seq, and the observation that H3K27me3 is highly predictive of steady state RNA levels has important practical implications. The manuscript is well-written and the figures are of high quality and easily comprehensible. I cannot entirely assess the modelling aspects of this paper (estimation of error in the linear model). This aspect should be evaluated by another reviewer. My major criticism is related to potential biases introduced by actinomycin D treatment and the lengthy analysis of miRNA-mediated effects which is in my opinion largely irrelevant for the work. The authors should also discuss translational and posttranslational regulation more carefully since regulation is also known to occur at these levels.
Major points:
1. Page 9, actinomycin D experiment: "Transcript abundance was determined in replicates at 0, 1, 2, 4 and 8 hours after inhibition of transcription, but not later in order to avoid secondary effects from long chemical treatment." This is a problematic experiment. Actinomycin D alters stabilities of mRNAs and therefore affects degradation rates. Importantly, this effect occurs already at 1 h and 2 h (see Fig 2 E in Dolken, RNA, 2008) . Therefore, it is impossible to "avoid secondary effects". Ideally, the authors should perform metabolic pulse labeling to quantify mRNA turnover in a less perturbed way. As a minimum, they should also use published RNA half-lives determined by metabolic labelling in other murine cells (Dolken 2008 , Schwanhauser 2011 , Rabani 2011 . Despite the different cell type the more accurate half-life measurement may lead to a better prediction.
2. Related to point 1, it is important to carefully discuss possible consequences of inaccurate halflife measurements. For example, the authors claim changes in mRNA half-lives contribute little to changes in mRNA levels between ES and TN (Suppl Fig. 8 ). This may of course be true. Alternatively, it could also reflect the better reliability of chip-seq data compared to the actinomycin D data. It is simply not known how good the actinomycin D half-lives reflect true half-lives of cellular RNAs, and there is published evidence that these measurements are problematic (see above). The biases introduced are systematic. Therefore, the high biological reproducibility of the actinomycinD data does not solve the fundamental problem.
3. microRNAs have been reported to inhibit translation and to induce degradation of target mRNAs. The authors did not investigate protein synthesis, so this aspect of miRNA function is irrelevant for the paper. miRNA-induced mRNA degradation is results in shorter mRNA half-lives. This point was assessed using actinomycin D experiments. I don't understand why the authors think that miRNAs should have an *additional* impact on posttranscriptional regulation: If they don't decrease mRNA half-lives, by which alternative mechanism do they expect miRNAs can contribute to the (small) discrepancy between the model and mRNA levels? Are they assuming a direct impact on transcription? If not, why was this point investigated at all? I think it contributes very little to the work and only distracts the reader from the main findings. It should be drastically shortened.
4. Page 10 "We controlled for the possibility that part of the effect would be explained by the chromatin marks used in the linear model before. This would be reflected in a co-variance between mRNA half-life and the regressors that predict transcription. Supplemental Figure 4 shows that this is not the case". I don't completely agree with the authors: Fig. S4 shows a considerable negative correlation between half-lives and polII occupancy / H3K36. As the authors state themselves, highly transcribed genes are depleted of short-lived transcripts. Therefore, histone marks and polII profiles are certainly not "unrelated" to mRNA half-lives as claimed. This should be discussed more carefully.
5. Page 17 "Furthermore we investigated the predictive power of histone marks towards changes in mRNA levels between the two cell types and find similarly that transcription is also the main determinant when looking at genes that change their expression." The final products of most genes are proteins. Therefore, gene expression cannot be assessed w/o measuring proteins. Actually, it has been shown that translation rate constants (i.e. translation efficiency) and not transcription rates are the single best predictor of protein abundance (Schwanhauser et al., Nature, 2011) . It is therefore possible that changes in translation rate constants are more important than changes in transcription rates when looking at genes that change their expression. The main determinant of changes in gene expression is currently not known.
Minor points:
6. "micro RNA" should be changed to ÑmicroRNA" throughout the paper 7. Page 6 "Rather than measuring transcription rates by metabolic labeling of RNA (Rabani et al, 2011; Min et al, 2011) ". Similar metabolic pulse labeling approaches by Dolken (RNA, 2008) and Schwanhauser (Nature, 2011) should also be mentioned.
8. It would be good to add error bars to the bar chart in Fig. 1D and other bar charts for correlation coefficients throughout the paper (Fig 5C etc) . This could be done by bootstrapping or some such.
9. Page 9 "short-lived genes" should be "short-lived RNAs" 10. Fig. S2 : It is not clear to me how R was calculated. It should of course be done on all data points. However, Fig. S2B shows box plots. Was R calculated on all data point or on average halflives?
11. The part on miRNA target prediction as an alternative way to define targets can be moved to the supplement -it is not relevant for the story. As stated above, I think the entire part on miRNAs is distracting and basically irrelevant here.
12. Page 18: The low impact of miRNAs on steady-state mRNA levels has been published before. However, it has also been shown by many labs that miRNAs can directly inhibit translation -an aspect the authors did not investigate here. It should be mentioned that a low impact of a miRNA on taret mRNA level does not necessarily mean that it has a low impact on expression of that gene (i.e. protein production).
13. Absolute quantification of RNA levels by next gen seq is complicated by genes which occur in multiple copies in the genome (genes for ribosomal proteins, pseudogenes etc.). For example, the mouse genome contains many pseudogenes for GAPDH. When weighting the alignments based on the number of hits this results in an underestimate. One way to correct for this effect is to calculate a "unique mappability score" by aligning in silico reads back to the genome (see Schwanhauser et al.) . This might further improve the performance of the model and should be tested.
Reviewer #3 (Remarks to the Author):
Tippmann et al. present an analysis of factors that quantitatively predict steady-state mRNA levels in dividing and post-mitotic cells. This work builds on a growing literature characterizing global determinants of gene expression. One novelty in the present work is the use of the overall pattern of H3K36 methylation, both around the transcription start site and further in the gene, as an improved predictor of mRNA abundance. The authors also provide independent evidence that mRNA turnover is a relatively minor factor controlling overall gene expression, in accordance with other recent studies. Perhaps most importantly, the authors extend their work to post-mitotic neurons, where differences in histone and mRNA dynamics may change their relationship with mRNA levels. This manuscript will certainly interest the MSB readership and the results will have a broader impact on related fields of science. I recommend its publication, provided that the authors can address the following specific concerns.
The quality of the mRNA abundance predictor is a key strength of this paper. Changes in this predictor in post-mitotic cells provide additional insights. I have two important questions related to the development of this predictor:
1. The authors find that H3K36 methylation provides the strongest correlation with mRNA abundance. This result contrasts with recent work by Cheng and Gerstein, who found that H3K36 had weaker predictive power than other chromatin marks. Here, Tippmann et al. quantify H3K36 methylation across the gene, which is expected to correlate better with transcription than H3K36 methylation just at the promoter. The authors discuss four separate regions where H3K36 methylation is quantified, but do not discuss how these regions individually correlate with expression or how the four measurements are combined into a predictor. Explaining this in more detail would address the differences between this work and the Cheng & Gerstein paper and provide a more detailed description of the ways in which this work specifically contributes to improved predictions of mRNA abundance.
2. The authors show strong correlations between mRNA abundance and H3K36 trimethylation, as well as with an overall linear model. However, it is clear that the correlations are not linear (a phenomenon seen for many chromatin marks by Cheng & Gerstein as well) and the authors never discuss this phenomenon. The authors do address this to some extent by the stratification of genes into low-and high-expression classes in Figures 5B and 5C . However, examination of graphs such as Figure 1C suggests that there is a smooth but non-linear relationship between H3K36me3 methylation and mRNA abundance. This is consistent with the model presented by the authors on p. 14, with low sensitivity in mitotic cells and saturation in post-mitotic cells. However, there are regression techniques that can handle these nearly-linear functions, e.g. by fitting low-order polynomials or by generating locally linear functions. The authors should address the non-linearity in their data that is revealed by the analysis in Figures 5B and 5C. This non-linear regression may also capture information from features such as H3K27 trimethylation, which clearly predicts the repression of a subset of transcribed genes but is absent from many totally silent genes.
I also have a few concerns about the mRNA degradation and miRNA targeting data.
3. Did the authors attempt to exclude genes where the actD treatment timecourse showed high interreplicate variance or fit poorly to linear degradation? 4. In Figure 2C , the authors show a modest effect of mRNA half-life on mRNA abundance in the three high transcription rate categories. However, paradoxical effects emerge in genes with low predicted transcription rates. Could these effects represent ascertainment bias in which genes with low transcription rate and short half-life are often discarded from the analysis, leaving only a biased subset with higher abundance? Are there other explanations that we should consider?
5. The authors average poly-A-enriched and rRNA-depleted RNA-seq abundance measurements. It would be helpful to look at the predictive power with each data set alone. Each approach may contain various artifacts, and some of these artifacts relate directly to RNA turnover processes. For instance, miRNAs can result in deadenylation of transcripts well in advance of decay, which would affect their apparent abundance differently in these two samples. It also appears that the nonpolyadenylated transcripts are dominated by the histones, which do in fact have a short half-life, but the situation is more complicated than the explanation given by the authors.
As a minor point, the authors use several compound words that are not, in fact, compound words in English: "RNA-interference", "polymerase-occupancy", "transcription-rate"
1
We thank the reviewers for their positive comments and constructive criticisms. We addressed all concerns in the revised manuscript by additional analysis and experiments. In particular we now provide a strict formalization of the linear model and discussion of the relation between transcription rate and mRNA concentration. Moreover we have established metabolic labeling in our lab and used it to experimentally measure genome-wide mRNA half-life in our cellular system and show that this alternative measure leads to similar conclusions. We hope the reviewers agree that these extensive revisions and the additional datasets make the manuscript suitable for publication. Below we provide a point by point response.
Reviewer #1

Tippmann et al. present a manuscript in which they describe data on mRNA expression levels, Pol II binding, histone methylation, mRNA half-lives and miRNA targets both in mouse terminally differentiated cells (TN) and in pluripotent stem cells (ES). The experiments appear to be well-performed and the results are presented in a clear manner. However, I cannot accept this paper in its current form due to the following major criticisms. The authors go into great depth in their explanation of the error models and the estimation of measurement noise. Well done. However, this is great contrast to several statistical issues I have with the analysis:
We thank the reviewer for these positive comments and the appreciation of the error modeling. We have addressed all raised issues as detailed below.
[ To better clarify this point we have now added a detailed note in the supplemental information section 1 in addition to formalizing the above in brief early in the manuscript. Furthermore, we edited the manuscript carefully separating, the term ʻrateʼ when used in context with the prediction of transcription and the term ʻlevelʼ for mRNA concentrations. We thank the reviewer for pointing this out.
[ Hebenstreit et al., Mol Sys Bio 2011) . Leaving this set out will improve several of the plots shown in the figures and likely change the authors' conclusions. If they prefer to leave the low-expression mRNAs in, I would want to see separate discussion of their properties and a justification. The reviewer is correct that there is a set of low-expression mRNA, while many might indeed be "off" several of these might be highly relevant even when expressed at very low levels. We nevertheless repeated the model fitting excluding mRNAs with an expression lower than 2 in log space (= low expressed genes, cut-off chosen based on the bimodal distribution of gene expression levels). The resulting explained variance of mRNA with predicted transcription is 76.8% compared to 84.6% when including low expressed genes. The correlation of the residual with the half-life is even higher than for the model that includes low expressed genes (0.39 versus 0.26). Since inclusion or exclusion of low expressed genes does not alter any conclusions we would argue to leave them in to avoid any a priori thresholding. The reviewer is also correct that the Pearson correlation coefficient cannot be used to determine the statistical significance of the observed correlation unless the data are normally distributed. This however is not the purpose for which we use the Pearson correlation coefficient. The decomposition of the total variance into additive contributions is a mathematically valid procedure irrespective of the nature and shape of the distribution functions (as long as the variance of the distribution exists, an assumption that we can safely make since expression levels and RNA concentrations are defined on a compact domain: bounded below by 0 and bounded above by the capacity of cell). In our setting, therefore, Pearson correlation coefficients are merely conveniently normalized variance contributions. Furthermore, in order to robustly measure correlation also for data deviating from a normal distribution, we computed rank order coefficients (spearman and kendall) of the correlations and display them in the plot for the respective cell type together with their (incomputable small) pvalues in the new supplemental figure 20.
[1D] Use of linear regression appears OK as most of the plots behave linearly (except for my criticism regarding bi-modality, 1C). However, I do not understand why the authors don't simply employ partial correlation analysis and multiple linear regression, but go through the somewhat convoluted pains of explaining their analysis of residuals. Please justify. I do not see why the analysis of residuals is valid over partial correlation analysis. (The authors may also want to discuss that they used linear correlation as an approximation but that that is not necessarily always correct).
We agree with the reviewer that some of our conclusions, in particular the fraction of explained variance by a regressor, could also be obtained by partial correlation analysis. We performed such analysis, which assigns 70.5% of the variance uniquely explained by chromatin derived measures, 3.6% uniquely explained by half-life and 6.3% commonly explained by both types of measures. As expected these results agree with our findings based on the analysis of residuals. Importantly however other findings in the manuscript, for example the dependency between cell proliferation rate and H3K36me3 levels in figure 5, would be difficult to infer without fitting a simple model. Similarly the relationship between post-transcriptional regulation and tissue-specificity (figure 6) becomes readily apparent by the analysis of residuals. In addition to these biologically relevant observation we also prefer the stepwise analysis from simple to more complex models since it is easier to understand for the reader.
[1E] The expression *change* between TN and ES cells is in fact a difference (as explained in the Supplement). Now, this is very unusual to see, since most of the time one would examine log-ratios of fold-changes in expression (log(m(TN)/m(ES)). I am concerned that using differences (especially since their are NOT used in log-space) produces data that is not normally distributed and causes all sorts of problems (reasoning: mRNA levels are not normally distributed in first place). Please explain why differences are used and how that is correct.
The expression change as we calculate it is in fact a log ratio, log(TN/ES)= log(TN)-log(ES), which we noted as ʻTN-ESʼ. As the reviewer pointed out correctly this might cause confusion and therefore we now explicitly use the ʻlogʼ term throughout the manuscript and introduce a shorter notation for the equations beforehand and thank the reviewer for pointing this out.
[ We note that we did not use a knockdown of DICER but a genetic deletion of the gene (Sinkkonen et al., 2008) . While this excludes any residual activity of DICER that might be present in knockdown approaches, the reviewer is right that there could be indirect effects in addition to the direct effects as in any loss of function experiment. Partly for that reason we also employed an alternative definition for miRNA targets using a purely computational approach (detailed in supplemental information section 8). While this has unrelated disadvantages (false postives due to short seed sequence etc.) it does not change our conclusion that the effect of microRNA targeting is limited. We hope the reviewer agrees that it is beyond the scope of this study to employ or develop more sophisticated approaches for miRNA target detection.
[3] Again, possibly linked to the confusion of 1. I do not see how chromatin features link to transcription rate. We likely have not pointed out the existing knowledge in the needed detail in the previous version of the MS. Tri-methylation of lysine 36 of histone H3 is directly linked to transcriptional elongation as the responsible methyltransferase directly and specficially interacts with the elongating RNA polymerase (Joshi & Struhl, 2005; Keogh et al., 2005; Kizer et al., 2005; Krogan et al., 2003; B. Li, Howe, Anderson, Yates, & Workman, 2003; J. Li, Moazed, & Gygi, 2002; Strahl et al., 2002; Sun, 2005; Xiao et al., 2003; Yuan et al., 2009) . As a consequence H3K36me3 decorates active genes ( (Barski et al., 2007; Bell et al., 2007; Mikkelsen et al., 2007; Pokholok et al., 2005) ) and importantly its abundance increases with every round of transcription and thus integrates transcriptional rate over time. While this mechanistic link between H3K36 tri-methylation and transcription rate was well established we now show that this enables surprisingly high prediction accuracy. We have expanded the respective explanations and references in the manuscript to make this point clearer.
[ The reviewer raises an important point. Indeed the mRNA half-lives of 21 hrs were derived by setting mRNAs with a longer half-life than what we could experimentally measure (based on our 8 hrs time course experiment, 20 hrs were determined to be the maximum half-life to extrapolate to) to this value. We agree that for the previous supplemental figure 4 (now highly revised as supplemental figure 21) these mRNAs should be disregarded as they distort the correlation coefficient. We have now included the actinomycin D derived half-times as a categorical variable with 5 levels into our linear model in order to account for the limitation to quantitatively determine long half-lives, which allowed us to keep all genes in the model. In addition, we now also include the thioU-derived data as an independent measure of half-lives. For both of these half-time measures, we now observe a weak correlation with mRNA levels as correctly predicted by the reviewer. This leads to a revised estimate for the regulation of the posttranscriptional level as it ranges between the 2% gained by adding half-lives to the linear model together with the transcriptional regressors and the upper bound of 11-12% explained variance using actinomycin D and thioU derived data alone. We thank the reviewer for pointing this out and note that this does not challenge our main observation of dominant regulation at the transcriptional level and the high predictive power of chromatin marks (see also directly related response to point 2.4).
[5] Is the mRNA level log transformed or not? (Supplemental calculations)
The mRNA levels, as well as all other (ChIP-) sequencing readouts, are log transformed for all analyses in the manuscript. We now mention it specifically in the supplemental information section 1 and for supplemental error calculations this is specifically stated at the beginning of supplemental information section 4.
Minor points:
[a] It would be nice to mention the organism in the abstract. We agree and have added to the abstract: "Using mouse as model organism, we show that chromatin features are sufficient to model RNA levels but with different sensitivities in dividing versus post-mitotic cells. "
[b] Please cite Mukherji, Nat Gen 2011 for the quote on miRNA as fine-tuners (p. 19)
We thank the reviewer for pointing out this reference and added it to the manuscript.
[c] p. 11 -leave out 'Surprisingly' as it is really not surprising given the indirect nature of the data
We changed the wording of the manuscript according to the reviewer suggestion.
[d] I think the analysis of tissue specificity is not particularly useful, but that's maybe personal taste
Tissue specific genes largely differ from ubiquitously expressed genes in regards to promoter structure, 3ʼUTR length, exon density and chromatin as discussed in the paragraph "Regulatory differences between tissue-specific and housekeeping genes" in the main text. These remarkable differences justify in our view to investigate if they differ in regards to transcriptional and posttranscriptional regulation. However, if the reviewer insists we can remove this analysis from the main text.
[e] The linear regression, at least some of the error modeling, calculation of expression DIFFERENCE, transcription RATE, and the modeling should be explained in the main text (Methods).
The term transcription rate, the linear regression and analysis of expression change are now discussed in the main text. Since the calculation of the error modeling in one and between two cell types is rather long, we kept it in the supplemental information 4. If the reviewer insists we are happy to move this into the main text if it is compatible with length restrictions of the journal.
[f] Figure 3C : I see a difference between orange and grey/blue boxes We agree that there seem to be a trend in the figure, however this occurs within bins that only harbor a small group of genes. In order to test significance of this trend we calculated the pearson correlation between residuals of the linear model and the log fold-change upon dicer knock-out (which corresponds to the difference between orange and blue boxes). We applied bootstrapping to calculate confidence intervals and illustrate the mean correlation of posttranscriptional measures with the residual of the linear model together with the p-value in supplemental figure 22, where error bars indicate 95% confidence intervals. This figure shows that the correlation of the log-fold-change upon dicer KO is not significantly correlated with the residual. (Rabani et al., 2011; Schwanhaeusser et al., 2011) 
This is a very interesting piece of work that addresses a fundamental question. The dominance of transcription rates over RNA stability was recently reported in two other papers and is therefore not completely new
. Nevertheless, this question was not yet addressed using chip seq, and the observation that H3K27me3 is highly predictive of steady state RNA levels has important practical implications. The manuscript is well-written and the figures are of high quality and easily comprehensible. I cannot entirely assess the modelling aspects of this paper (estimation of error in the linear model). This aspect should be evaluated by another reviewer. My major criticism is related to potential biases introduced by actinomycin D treatment and the lengthy analysis of miRNA-mediated effects which is in my opinion largely irrelevant for the work. The authors should also discuss translational and posttranslational regulation more carefully since regulation is also known to occur at these levels.
We thank the reviewer for the very positive remarks and have addressed all concerns as detailed below. We especially addressed the reviewers question concerning actinomycin D treatment experimentally and established and performed metabolic labeling as an alternative method to measure mRNA halflife.
[1] Page 9, actinomycin D experiment: "Transcript abundance was determined in replicates at 0, 1, 2, 4 and 8 hours after inhibition of transcription, but not later in order to avoid secondary effects from long chemical treatment." This is a problematic experiment. Actinomycin D alters stabilities of mRNAs and therefore affects degradation rates. Importantly, this effect occurs already at 1 h and 2 h (see Fig 2 E in Dolken, RNA, 2008). Therefore, it is impossible to "avoid secondary effects". Ideally, the authors should perform metabolic pulse labeling to quantify mRNA turnover in a less perturbed way. As a minimum, they should also use published RNA half-lives determined by metabolic labelling in other murine cells (Dolken 2008, Schwanhauser 2011, Rabani 2011). Despite the different cell type the more accurate half-life measurement may lead to a better prediction.
Motivated by the reviewerʼs suggestion we have now performed metabolic labeling at the stem cell stage followed by microarray detection on the same platform that we used for the RNA decay measurements. These results are part of the new supplemental information section 6. In the new supplemental figure 10 we show that thioU incorporation into RNA is concentration dependent while supplemental figure 11 shows the high reproducibility between three biological replicates. In the new supplemental figure 12 we contrast RNA half-life measurements by actinomycin and thioU treatment versus the residual of the linear model. This shows that both half-life measurements performed in the same cells and with the same genomics platform reveal similarly small contribution to mRNA levels. We thank the reviewer for the suggestion to include metabolic labeling as an alternative. We hope she/he appreciates the effort and agrees that this argues strongly that our finding of a limited contribution of half-life was not caused by indirect effects related to actinomycin treatment. Fig. 8 We agree with the reviewer that high reproducibility does not translate into absence of indirect effects and we never intended to make such claim. The best argument that our findings are not based on indirect effects related to actinomycin treatment is there independent validation with thioU labeling, which are included in the revised manuscript (see also answer to reviewer #2, question 1). We thank the reviewer for suggesting these experiments, which strongly improve the manuscript.
[2] Related to point 1, it is important to carefully discuss possible consequences of inaccurate half-life measurements. For example, the authors claim changes in mRNA half-lives contribute little to changes in mRNA levels between ES and TN (Suppl
[3] microRNAs have been reported to inhibit translation and to induce degradation of target mRNAs. The authors did not investigate protein synthesis, so this aspect of miRNA function is irrelevant for the paper. miRNA-induced mRNA degradation is results in shorter mRNA half-lives. This point was assessed using actinomycin D experiments. I don't understand why the authors think that miRNAs should have an *additional* impact on posttranscriptional regulation: If they don't decrease mRNA half-lives, by which alternative mechanism do they expect miRNAs can contribute to the (small) discrepancy between the model and mRNA levels? Are they assuming a direct impact on transcription? If not, why was this point investigated at all? I think it contributes very little to the work and only distracts the reader from the main findings. It should be drastically shortened.
We did not mean to imply an additional role for miRNA in degradation and have carefully reviewed the text to avoid giving this impression. In light of the ongoing debate around the mode of action of miRNA at the level of translation as well as degradation we were interested in an identifiable contribution of microRNAs to degradation (half-life) in general. While we believe that this justifies the effort and warrants its inclusion we would be willing to further reduce this part if this reviewer insists.
[ The reviewer is correct in that there is indeed a correlation of H3K36me3 as well as Pol-II occupancy with mRNA half-life. This escaped our attention since we left the 21hr half-life transcripts in our set. We have now removed these long-lived transcripts in our analysis. Furthermore we also performed this analysis using mRNA half-life data from the newly added metabolic labeling experiment, which is not temporally limited. Supplemental figure 21 (former supplemental figure 4) shows the resulting plots for the actinomycin treatment.
The maximum correlation observed is limited to 0.36, weak compared to the correlation between H3K36 and RNA and thus does not challenge our conclusion that mRNA levels are predominantly regulated at the transcriptional level. We assume that the weak correlation between chromatin and half-life reflects convergent evolution of two variables that contribute to high transcript level (high rate of transcription and extended half-life) rather than reflecting a mechanistic or causal link. As an upper estimate for the regulation of the posttranscriptional level we used half-lives alone to predict mRNA levels resulting in 11-12% of explained variance for actinomycin D and thioU derived data. We conclude that the share of post-transcriptional regulation, measured as percent of explained variance of mRNA amounts, is between the 2% gained by adding half-lives to the linear model together with the transcriptional regressors, and the upper bound of 12%. We added this new analysis, removed the misleading sentence and thank the reviewer for pointing this out to us.
[5] Page 17 "Furthermore we investigated the predictive power of histone marks towards changes in mRNA levels between the two cell types and find similarly that transcription is also the main determinant when looking at genes that change their expression." The final products of most genes are proteins. Therefore, gene expression cannot be assessed w/o measuring proteins. Actually, it has been shown that translation rate constants (i.e. translation efficiency) and not transcription rates are the single best predictor of protein abundance (Schwanhauser et al., Nature, 2011) . It is therefore possible that changes in translation rate constants are more important than changes in transcription rates when looking at genes that change their expression. The main determinant of changes in gene expression is currently not known. We never meant to imply that transcription is more relevant than translation, particularly since we do not measure it. We agree that our wording could be misleading and have changed it accordingly throughout the text. We thank the reviewer for pointing this out.
Minor points:
[a] "micro RNA" should be changed to "microRNA" throughout the paper We changed in to "microRNA" throughout the text and thank the reviewer for pointing this out.
[b] Page 6 "Rather than measuring transcription rates by metabolic labeling of RNA (Rabani et al, 2011; Min et al, 2011) ". Similar metabolic pulse labeling approaches by Dolken (RNA, 2008) and Schwanhauser (Nature, 2011) should also be mentioned. We thank the reviewer to point out these references and added them to the manuscript.
[c] It would be good to add error bars to the bar chart in Fig. 1D and other bar charts for correlation coefficients throughout the paper (Fig 5C etc) . This could be done by bootstrapping or some such. We agree that addition of error bars would be informative. To calculate the correlation coefficients between regressors and mRNA levels we performed bootstrapping with 10.000 samplings each. We added error bars to the plots in Figure 1D and 5C representing the 95% confidence interval obtained from bootstrapping.
[d] Page 9 "short-lived genes" should be "short-lived RNAs" We agree that RNAs would be a better wording in this context and changed the manuscript according to the reviewer suggestions.
[e] Fig. S2 : It is not clear to me how R was calculated. It should of course be done on all data points. However, Fig. S2B shows box plots. Was R calculated on all data point or on average half-lives?
Yes, the correlation was calculated on all data points, boxplots were only used for better illustration of the small correlations. The boxplots from figure S2B are now separated in each respective section of the supplemental information, supplemental figure 9 and 12 for mRNA half-life and 13 and 16 for effect of microRNA by the two different methods. A summary of these boxplots showing correlation of each post-transcriptional effect with the residual of the linear model including their significance is shown in the new supplemental figure 22.
[f] The part on miRNA target prediction as an alternative way to define targets can be moved to the supplement -it is not relevant for the story. As stated above, I think the entire part on miRNAs is distracting and basically irrelevant here. As pointed out above (2.3) we feel that the ongoing discussion on microRNA contribution to mRNA levels justifies presenting this in the main manuscript if space permits. However, we are willing to shorten this part if the reviewer insists.
[g] Page 18: The low impact of miRNAs on steady-state mRNA levels has been published before. However, it has also been shown by many labs that miRNAs can directly inhibit translation -an aspect the authors did not investigate here.
It should be mentioned that a low impact of a miRNA on taret mRNA level does not necessarily mean that it has a low impact on expression of that gene (i.e. protein production).
The reviewer is correct in that there are two main hypotheses in the field of microRNA-targeting mechanism: microRNAs act on the level of degradation of the transcript ( (Guo, Ingolia, Weissman, & Bartel, 2010) ) or miRNAs inhibit translation ( (Ding & Grosshans, 2009; Fabian, Sonenberg, & Filipowicz, 2010; Hurschler, Ding, & Grosshans, 2010) ). There are notably many examples on increase of transcript abundance upon deletion of microRNA or part of the RNAi machinery ( (Fabian et al., 2010) ). We are fully aware of this ongoing debate but in the scope of the study we only measure mRNA levels as the ʻendpointʼ. Therefore we cannot make any claim on translational regulation or protein levels. As far as mRNA levels are concerned, we only state that the impact of miRNAs on target mRNAs is low.
[h] Absolute quantification of RNA levels by next gen seq is complicated by genes which occur in multiple copies in the genome (genes for ribosomal proteins, pseudogenes etc.). For example, the mouse genome contains many pseudogenes for GAPDH. When weighting the alignments based on the number of hits this results in an underestimate. One way to correct for this effect is to calculate a "unique mappability score" by aligning in silico reads back to the genome (see Schwanhauser et al.) . This might further improve the performance of the model and should be tested. The reviewer raises a valid point since reduced mappability could indeed lead to an underestimation of mRNA levels. As suggested by the reviewer, we calculated a mappability score m for each transcript in our dataset. We aligned all 36mer subsequences of each refSeq transcript in the same way as we analyzed the experimental sequencing data, and identified uniquely mappable reads. A mappability score was calculated as the ratio of uniquely mappable 36mers over the total number of 36mers per transcript. We added the new supplemental figure 23 to illustrate the result of this analysis. 95% of the transcripts have a mappability score larger than 0.79 and more than 40% of the transcripts consist only of mappable 36mers (mappablity score = 1) (upper left panel). The reviewer is correct in pointing out that genes with mappability scores below one are underestimated in their expression and might cause a bias in the linear model. We separate the 5% transcripts with the lowest mappability score in red and do not find a significant difference in the density distributions of residuals from these transcripts vs. the other 95% (upper right panel). Additionally, when marking the 5% of genes with lowest mappability scores in supplementary figure 23 (lower panel) we do not find a systematic bias. We conclude that reduced mappablity has only a very limited effect and thus that correcting for it will not improve the model. We thank the reviewer for the very positive comments about our work and its foreseen broad impact. (Cheng & Gerstein, 2011) H3K36me3 is a weaker predictor for mRNA levels compared to our study. A similar result was presented in (Karlic, Chung, Lasserre, Vlahovicek, & undefined author, 2010) , where the authors used maps of 38 histone modifications to predict mRNA levels. Both studies, in contrary to our manuscript, constrain their analysis of histone marks to regions around transcription start sites, where many, but not all, active histone marks show their strongest signal. However, H3K36me3 is a histone mark set by the elongating polymerase in a process that only begins a few hundred bases downstream from the start. Therefore even at active genes its abundance at the promoter is low but high over the transcribed regions. As a consequence it is thus much more predictive when integrated over the whole gene body (also see response to reviewer #1, question 3). To investigate the behavior of this mark in more detail we plotted H3K36me3 along the gene body, separating reads which map into exons and introns respectively (supplemental figure 2) . We see that the H3K36me3 mark rises the first 2kb after the TSS and then plateaus from 2kb to the end of the gene body. Therefore we treated reads within the TSS-region and gene-body region as separate regressors. Secondly, we see a higher enrichment for H3K36me3 in exons than introns, which is in accordance with other studies (Schwartz, Meshorer, & Ast, 2009) , potentially holding information and giving more predictive power to the H3K36me3 histone mark. The four regions in which H3K36me3 reads were mapped in our study are illustrated in supplemental figure 3. To illuminate why this histone mark has a higher predictive power in our model as compared to the study of (Cheng & Gerstein, 2011) we plot H3K36me3 reads mapped the each of the 4 regions versus mRNA level of the respective in gene in the newly added supplemental figure 4 and indicate the explained variance respectively. We show that H3K36me3 measured within the gene body is a significantly better predictor of mRNA levels than the same mark measured around TSS, even more so if we focus on exons within the gene body (r 2 =0.79 for exons in gene body vs. The reviewer raises a number of valid points. In the previous version of the MS we briefly discussed the origin of this non-linearity, both on the lower and upper end of mRNA abundance. Motivated by the above and similar comments from reviewer 1 we now developed a non-linear model in order to better capture the behavior of predicted transcription vs. mRNA level. We subsequently transform our predicted transcription value according to the derived model and infer the predictive power towards mRNA levels again. A description of derivation of the complex function for the model and parameters for model fitting is detailed in supplemental information 11. This analysis reveals that the non-linearity (an inverse sigmoid) only applies to a small interval and that most of the mRNA can be indeed captured by a linear model. The difference in predictive power between the linear and the partially non-linear model is marginal and therefore justifies in our option the simplification to a linear model. We only want to make a statement about half-life for genes where we can detect expression in arrays of all time points. Therefore we discard genes, which have an RMA expression value less than 3 (in log2 space). For the remaining genes (large majority) we infer the decay-slope using both replicates together as illustrated in supplemental figure 5B. For each gene we calculate an r-squared of linear regression modeling expression vs. time as a quality measure of how much each the array replicates at different time points fit to the linear degradation (with 72% of mRNAs having a r-squared > 0.5). We assessed whether excluding mRNA with an r-squared of their decay model less than 0.1, 0.2 or 0.4 thresholds results in a more pronounced contribution of mRNA half-life to mRNA levels. However, we do not see this effect, concluding that genes with a ʻrather noisyʼ decay measure do not affect the relative contribution of mRNA decay to mRNA levels.
Reviewer #3
[4] In Figure 2C , We think that there are two causes contributing to the effect pointed out by the reviewer: Primarily the predictive power of the linear model composed of histone marks is lower in weakly expressed genes (as assessed by calculating the pearson correlation in each bin of predicted transcription). This is most likely due to the fact that chromatin-IP, our experimental measure for H3K36me3 is not sensitive enough for very few me3 residuals, therefore for the low abundant transcripts we see an increase in mRNA level where we do not see a corresponding increase in H3K36me3, yet. Secondly, the reviewer is right, there is a bias towards having less short-lived mRNAs in the predicted to be lowly transcribed bins. This is illustrated in supplemental figure 8 (former supplemental figure 2 ). Therefore the orange, short-lived mRNAs, in the two lower bins of predicted transcription contain only a small number of genes and their distribution (visualized as boxplot in figure 2C ) cannot be stably estimated.
We have tried to make this point clearer in the text.
[ + iMir + 0 + 0 + 0 The reviewer raises a valid point. We have now repeated our analysis, predicting transcription from histone marks and mRNA half-life with different response variables: instead of using an average of mRNA abundance obtained by different library preparation protocols, we now train and predict with either total, strand specific RNA which was obtained by depletion of rRNA or with mRNA obtained by polyA enrichment. The results of this analysis are summarized in the table above. We agree with the reviewer that each RNA-seq approach may have its own artifacts, however the results of this side-by-side analysis show that the choice of mRNA response variable does not change the conclusion. We are happy to add the above table into the supplemental material. Minor Point: [a] As a minor point, the authors use several compound words that are not, in fact, compound words in English: "RNA-interference", "polymerase-occupancy", "transcription-rate" We thank the reviewer for the grammatical corrections and fixed these oversights.
1. The authors show that the RNA half-life measurements determined by metabolic labeling correlate well with each other. However, they do not test the correlation between half-lives measured by actinomycin D treatment and those from metabolic labeling. The extent of correlation between these two measurements would indicate the extent to which errors in both measurements diminished the apparent contribution of mRNA half-life to steady-state levels. This is a valid point, which we addressed by including a pairwise comparison between both measures (Supplemental Information #6, middle panel Supplemental Figure 12 ). Despite that both approaches are very different in setup (time-course versus single measurement) and experimental procedures (inhibitor addition versus labeling followed by immunoprecipitation of RNA) we observe a significant correlation (R=0. 35, p<2.22e -16 ). This precludes that the measurements are completely dominated by noise. The reviewer is right that in the absence of perfect measurements we cannot exclude that we underestimate the relative contribution of half-life. Accordingly we have also changed the description in the results section on page 10 to make this limitation more obvious and thank the reviewer for pointing this out.
2. The authors also comment that metabolic labeling "...it is limited to a single time point." While the authors test only a single timepoint in this work (and I do not mean to suggest that they need to test more), I don't see why the technique could not be used at multiple timepoints, with the extent of mRNA turnover indicated by the extent of labeling.
The reviewer is right that this method could in theory be applied in a timecourse and we have changed the text accordingly. We note however that we are not aware of a time-course series using metabolic labeling.
3. The authors fit one specific nearly-linear model to their data, using a sigmoid to account for potential saturation of H3K36Me3. However, looking at e.g. Supplemental Figure 19 , it looks like the residual on the linear segment is not uniform, though such dense scatter plots can be misleading. None of this addressed the strong non-linearity (in fact, non-functionality) in some of the other chromatin marks, either. The authors probably have plenty of data to perform LOESS and fit more powerful predictors.
The reviewer is right that the specific non-linear model selected for the fit in supplemental information #11 is one of many possible models. We have now also performed a LOESS fit as suggested by the reviewer (using loess() as implemented in R, with default parameters except for span=0.3). In addition, we are now showing the local density of data points as color shades, improving the overprinting issue. The resulting LOESS fit is shown in the figure below (right panel), compared to the original linear fit (left panel): This results in a small increase in residual correlation with RNA half-life (from 0.296 to 0.305). This result is fully in agreement with our conclusions based on the simple linear model, and we think that the small increase of correlation does not justify the use of this more complex model.
4. In the abstract, the authors discuss "Primary transcriptional regulation at the levels of chromatin" but this seems to beg the question--transcriptional regulation need not act at the level of chromatin. In fact, the authors ultimately find that chromatin marks that are downstream of transcription (and thus transcriptional regulation) predict mRNA abundance best.
With this wording we did not mean to imply that transcription is regulated at the level of histone modification and we changed it to "at the chromosomal level" to exclude such impression.
5. The authors mention the dilution of H3K36Me3-modified histones by division--however, mRNAs themselves are also diluted by division, which is another factor influencing the effective half-life of mRNAs.
We discuss cell division as a biological explanation for the differential sensitivity of H3K36me3 between dividing and non-dividing cells. Cell division however is not part of any modeling and is further highly reduced by actinomycinD treatment.
